## Metrics Summary

- **Primary metric:** `region_level_contamination_error`
- **Reported direction:** **lower is better**
- **Run status:** **failed**
- **Seeds:** 5 total noted, but reported effectively as **`n=1` per cell**
- **Most important benchmark slice:** `matched_background_or_shared_context`
- **Key issue:** the numeric patterns and the narrative are in tension. If lower is better, several “improved” variants are actually worse than vanilla in the reported numbers.

Illustrative values mentioned across perspectives:

- **VanillaFreeCustomMRSA**
  - overall: **0.063727**
  - matched/shared-context: roughly **0.1006–0.1050**
  - clean/mismatched-context: roughly **0.0238–0.0244**

- **ForegroundDeconfoundedConflictRoutedMRSA**
  - overall: **0.066970**
  - matched/shared-context: around **0.108–0.111**
  - clean/mismatched-context: around **0.0253**

Under the stated metric direction, this is **worse than vanilla overall, on the hard subset, and on the clean subset**.

---

## Consensus Findings

High-confidence conclusions shared across the three perspectives:

1. **This is exploratory, not confirmatory evidence.**  
   All three perspectives agree the run is underpowered and incomplete. The combination of `status: failed`, 5 seeds, and `n=1` per reported cell means the results cannot support strong claims.

2. **The matched/shared-context subset is the right stress test.**  
   There is agreement that shared-context / matched-background cases are the intended failure mode and are the most relevant benchmark slice for this hypothesis.

3. **The experimental decomposition is directionally good.**  
   The ablations attempt to separate similarity weighting, deconfounding, routing, scheduling, and residual boosting. That is a sensible mechanism-oriented design, even if the execution/reporting is not yet sufficient.

4. **A critical baseline is missing or inconsistently reported.**  
   `GlobalSimilarityWeightedMRSA` appears in the registered conditions but not clearly in the quantitative outputs. Since the core claim is local deconfounded routing vs global similarity gating, this omission is severe.

5. **Metric/reporting integrity must be resolved before interpretation.**  
   The stated metric direction (“lower is better”) appears inconsistent with the positive narrative around larger values on subset results. This could reflect a sign error, table bug, or interpretation mistake.

---

## Contested Points

### 1. Do the current results support the hypothesis?
**Judgment:** **No, not as reported.**

- The optimist sees directional promise in the hard subset.
- The skeptic and methodologist point out that the actual numbers, assuming lower is better, do **not** support that reading.

**Evidence-based resolution:**  
The skeptic/methodologist have the stronger case here. With the current metric direction, the proposed full method appears inferior to vanilla. Unless the metric direction or table values are wrong, the central hypothesis is **not supported** by these results.

### 2. Are the ablations already scientifically useful?
**Judgment:** **Yes, but only as pilot instrumentation.**

- The optimist is right that the ablation structure is informative.
- But that does not imply evidentiary strength.

**Resolution:**  
Treat the study as a **useful pilot** that helps identify what to test next, not as evidence that adaptive MRSA works.

### 3. Is there still a promising research signal?
**Judgment:** **Possibly, but weakly established.**

There may be a signal because:
- the benchmark slices are meaningful,
- some variants change behavior in structured ways,
- the clean subset seems relatively clustered.

But at present this is only a **hypothesis-generation signal**, not validation.

---

## Statistical Checks

1. **No valid uncertainty estimation**
   - `n=1` per cell means no variance, no CI, no standard error.
   - No significance testing is possible from the presented table.

2. **Seed aggregation is missing**
   - The run used 5 seeds, but results were not aggregated properly across seeds/prompts.
   - Minimum needed: mean, SD, bootstrap CI, and **paired deltas vs vanilla** on identical prompts/seeds.

3. **Multiplicity risk is high**
   - Many variants and multiple slices were compared.
   - No preregistered primary endpoint analysis or multiple-comparison control is reported.

4. **Direct numeric check contradicts the claim**
   Assuming lower is better:
   - Proposed vs vanilla overall: **0.066970 vs 0.063727** → about **5.1% worse**
   - Proposed vs vanilla matched/shared-context: **0.110118 vs 0.103694** → about **6.2% worse**
   - Proposed vs vanilla clean subset: **0.025301 vs 0.023800** → about **6.3% worse**

5. **Result quality rating: 3/10**
   - **+2** for having a relevant hard subset and decent ablation intent
   - **+1** for some structured experimental design
   - **-3** for failed run / incomplete execution
   - **-2** for no uncertainty or proper replication analysis
   - **-1** for missing key baseline
   - **-1** for possible metric direction/reporting inconsistency

A score of **3/10** reflects that the experiment is **useful as a pilot**, but **not reliable enough for substantive scientific conclusions**.

---

## Methodology Audit

### Strengths
- Good instinct to stratify by **shared-context vs clean-context**
- Reasonable mechanism decomposition:
  - similarity-only
  - routing without deconfounding
  - deconfounded routing
  - scheduling variants
  - residual variants
- Focus on region-level contamination is more aligned than whole-image metrics alone

### Major gaps needing address

1. **Missing key comparator**
   - `GlobalSimilarityWeightedMRSA` must be present and clearly reported.

2. **Metric definition and directionality not trustworthy yet**
   - Exact formula, weighting, normalization, and sign convention need verification.
   - Show sanity-check examples where the metric clearly increases/decreases appropriately.

3. **Run integrity failure**
   - A failed run should not serve as main evidence.
   - Need a clean rerun with all registered conditions completed.

4. **Insufficient statistical design**
   - Increase to at least a more stable seed count.
   - Aggregate across prompts and seeds.
   - Use paired analyses and bootstrap confidence intervals.

5. **Metric validation is incomplete**
   - Add:
     - per-concept identity retention
     - cross-concept leakage
     - prompt alignment
     - realism/aesthetics
     - human pairwise evaluation

6. **Potential evaluator-method entanglement**
   - If masks/CLIP-like features are used in both routing and evaluation, independent evaluation channels are needed.

7. **No clear fairness/computation accounting**
   - Report inference overhead, memory cost, and whether baselines received equivalent tuning and side information.

---

## Limitations

1. **Failed execution context** undermines trust in completeness and consistency.
2. **`n=1` per reported cell** makes statistical claims impossible.
3. **Missing central baseline** leaves the main hypothesis untested.
4. **Possible sign/reporting bug** may invalidate current interpretation altogether.
5. **Single custom metric** is too narrow for a composition-quality claim.
6. **No human evaluation or external metric triangulation**.
7. **No clear held-out dev/test protocol** for threshold/schedule selection.

---

## 3–5 Key Findings

1. **The study does not currently validate the main claim.**  
   As reported, the proposed deconfounded conflict-routed MRSA does not beat vanilla on the primary metric.

2. **The benchmark framing is probably sound.**  
   Shared-context / matched-background cases remain the right place to test the mechanism.

3. **The strongest methodological blocker is not model quality but evaluation quality.**  
   Missing baseline, failed run, and metric ambiguity are bigger issues than which ablation currently “wins.”

4. **The ablation program is promising as a pilot.**  
   The component breakdown is worth preserving for a rerun because it is aligned with the causal question.

5. **A clean rerun could still be valuable, but only after fixing reporting and metric integrity.**

---

## Conclusion

### Recommendation: **REFINE**

Not **PROCEED**, because the current evidence is too weak and internally inconsistent.  
Not full **PIVOT**, because the underlying research question and benchmark framing still look worthwhile.

### Clear judgment
Refine the experiment before drawing conclusions or investing heavily in the current narrative.

### Immediate next actions
1. **Rerun successfully** with all registered conditions, especially `GlobalSimilarityWeightedMRSA`.
2. **Audit the metric sign/direction and table generation** end-to-end.
3. **Aggregate results properly across prompts and seeds** with paired uncertainty estimates.
4. **Add complementary metrics and a small human study**.
5. **Freeze a confirmatory evaluation plan** centered on the matched/shared-context subset.

If those fixes still show the proposed method beating vanilla and global similarity gating on the hard subset with acceptable tradeoffs, then the program can move forward credibly. As of now, the truth is: **interesting pilot, but not validated evidence.**